1. Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from grupo argentino de mieloma múltiple. Issue 3 (4th March 2021) Authors: Duarte, Patricio Jose; Schutz, Natalia Paola; Ochoa, Paola; Yantorno, Sebastian; Orlando, Sergio; Lopresti, Sergio; Zabaljauregui, Soledad; Aizpurua, Florencia; Shanley, Claudia; Giannini, Elvira; Garate, Gonzalo; Foncuberta, Cecilia; Milone, Jorge; Riveros, Dardo; Fantl, Dorotea Journal: Expert review of hematology Issue: Volume 14:Issue 3(2021) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH). Issue 14 (6th December 2022) Authors: Warley, Fernando; Berro, Mariano; Palmer, Silvina; Castro, Martin; Ferini, Gonzalo; Lopez Orozco, Milagros; Otero, Victoria; Arbelbide, Jorge; Foncuberta, Cecilia; Yantorno, Sebastián; Basquiera, Ana Journal: Leukemia & lymphoma Issue: Volume 63:Issue 14(2022) Page Start: 3508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗